Chronic blockade of nitric oxide-synthase and endothelin receptors during pregnancy in the rat: Effect on pregnancy outcome

Journal of the Society for Gynecologic Investigation

Volumn 5, Issue 3, 1998, Pages 132-139

  Wight, Edward ^a,b   Küng, Christoph F ^a,b   Moreau, Pierre ^a,b   Takase, Hiroyuki ^a,b   Lüscher, Thomas F ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acetylcholine; Bosentan; Endothelin 1; N( ) nitro L arginine methyl ester (L NAME); Preeclampsia; Rat pregnancy

Indexed keywords

BOSENTAN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BIRTH RATE; BODY WEIGHT; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HEMODYNAMIC MONITORING; HYPERTENSION; MORTALITY; NONHUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR BLOCKING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY WEIGHT; FEMALE; FETUS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORGAN SIZE; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, ANIMAL; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SULFONAMIDES; TIME FACTORS;

EID: 0345404239     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(98)00004-5     Document Type: Article

References (42)

1. Lüscher TF, Vanhoutte PM. The endothelium Modulator of cardiovascular function . 1990;CRC Press, Boca Raton.
2. Lüscher TF, Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol. 24:(Suppl 3):1994;S16-S26.
3. Rapoport RM, Murad F. Agonist induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res. 52:1983;352-357.
4. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanoside monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1774-1777.
5. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
6. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 91:1995;1314-1319.
7. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 91:1994;5212-5216.
8. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol. 24:1984;175-197.
9. Rees DD, Palmer RMJ, Schulz R. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 101:1990;746-752.
10. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta Inhibition by endothelium-derived nitric oxide . J Clin Invest. 85:1990;587-590.
11. Yokokawa K, Khono M, Yasunari K, Murakawa K, Horio T, Takeda T. Endothelin-3 regulates endothelin-1 production in cultured human endothelial cells. Hypertension. 18:1991;304-315.
12. Stewart DJ, Langleben D, Cernacek P, Cianflone K. Endothelin release is inhibited by coculture of endothelial cells with cells of vascular media. Am J Physiol. 259:1990;H1928-H1932.
13. Yoshimoto S, Ishizaki Y, Sasaki T, Murota S. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke. 22:1991;378-383.
14. Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, Ogihara T. Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochemical Biophys Res Commun. 159:1989;1304-1308.
15. Konishi M, Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension. 5:1983;881-886.
16. Lüscher TF, Vanhoutte PM. Endothelium-dependent responses to aggregating platelets and serotonin in spontaneously hypertensive rats. Hypertension. 8:(Suppl 2):1986;55-60.
17. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilatation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 21:1993;929-933.
18. Nava E, Noll G, Lüscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation. 91:1995;2310-2313.
19. Tanner FC, Noll G, Boulanger CM, Lüscher TF. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries Role of scavenger receptor and endothelium-derived nitric oxide . Circulation. 83:1991;2012-2020.
20. Grieff M, Lörtscher R, Shohaib SA, Stewart DJ. Cyclosporine induced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation. 56:1993;880-884.
21. Goerre S, Wenk M, Bartsch P, et al. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation. 91:1995;359-364.
22. Boulanger C, Tanner FC, Hahn AWA, Werner A, Lüscher TF. Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from the human and porcine endothelium. Circ Res. 70:1992;1191-1197.
23. Kamoi K, Sudo N, Ishibashi M, Yamaji T. Plasma endothelin-1 levels in patients with pregnancy-induced hypertension. N Engl J Med. 323:1990;1486-1487.
24. Schiff E, Ben-Baruch G, Peleg E, et al. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol. 166:1992;624-628.
25. MacGillivray I, Rose GA, Rowe B. Blood pressure survey in pregnancy. Clin Sci. 37:1969;395-407.
26. Peeters LL, Grutters G, Martin CB. Distribution of cardiac output in the unstressed pregnant guinea pig. Am J Obstet Gynecol. 138:1980;1177-1184.
27. Palmer SK, Zamudio S, Coffin C, Parker S, Stamm E, Moore LG. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol. 80:1992;1000-1006.
28. Weiner CP, Thompson LP, Liu K, Herrig JE. Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am J Obstet Gynecol. 166:1992;1171-1181.
29. Magness RR. Endothelium-derived vasoactive substances and uterine blood vessels. Semin Perinatol. 15:1991;68-78.
30. Buñag R, Butterfield J. Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension. 4:1982;898-903.
31. Takase H, Moreau P, Küng CF, Nava E, Lüscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension. 27:1996;25-31.
32. Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 270:1994;228-235.
33. Baylis C, Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exp Hypertens Pregnancy. B11:1992;117-129.
34. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 169:1993;1316-1320.
35. Molnár M, Süto T, Tóth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinurea, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 170:1994;1458-1466.
36. Helmbrecht GD, Farhat MY, Lochbaum L, et al. L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol. 175:1996;800-805.
37. Richard V, Hogie M, Clozel M, Löffler B, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 91:1995;771-775.
38. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension. 24:1994;183-188.
39. Masaki T, Usuki S, Yanagisawa M, Suzuki N. Endothelin in perinatal pharmacology. Semin Perinatol. 15:1991;27-29.
40. Diket AL, Pierce MR, Munshi UK, et al. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol. 171:1994;1243-1250.
41. Kurihara Y, Kurihara H, Suzuki H. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 368:1994;703-710.
42. Jaffer FE, Knauss TC, Poptic E, Abboud HE. Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney Int. 38:1990;1193-1198.